Nuzenio

Janux Therapeutics Reports

Janux Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Bank of America Securities Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:58:00 GMT Janux Therapeutics, Inc. (JANX) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 03:47:32 GMT Janux Therapeutics, Inc. (JANX) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 23:06:38 GMT Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:20:03 GMT Janux Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:59:46 GMT Janux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMT Janux Therapeutics (NASDAQ: JANX) posts Q2 loss on collaboration revenue - Stock TitanStock Titan · Thu, 06 Aug 2026 20:18:43 GMT Janux Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 20:18:00 GMT

Timeline

Sat, 08 Aug 2026 10:58:00 GMTBank of America Securities Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX) - The Globe and Mail

Fri, 07 Aug 2026 03:47:32 GMTJanux Therapeutics, Inc. (JANX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Thu, 06 Aug 2026 23:06:38 GMTJanux Therapeutics, Inc. (JANX) stock price, news, quote and history - Yahoo Finance Singapore

Thu, 06 Aug 2026 21:20:03 GMTJanux Therapeutics, Inc. (JANX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Thu, 06 Aug 2026 20:59:46 GMTJanux Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 20:35:07 GMTJanux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

JANX12 live mentions Janux Therapeutics12 live mentions Inc10 live mentions June4 live mentions Therapeutics3 live mentions Yahoo Finance Singapore3 live mentions TradingView Janux Therapeutics3 live mentions Second Quarter3 live mentions America Securities Sticks2 live mentions Its Buy Rating2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Janux Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.